Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on February 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants to ten new employees, ...
In addition to Stifel Nicolaus, Immunovant also received a Buy from H.C. Wainwright’s Douglas Tsao in a report issued yesterday. However, on February 9, Truist Financial maintained a Hold rating on ...
Neurocrine Biosciences, Inc. today announced its financial results for the fourth quarter ended December 31, 2025. "Our ...
Nearly 200 cat caregivers in the Des Moines, Iowa, area received no-cost Trap-Neuter-Return (TNR) support and cat food this week, all provided by Alley Cat Allies in collaboration with the Animal ...
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
The table below is a review of notable updates that occurred in January 2026 for investigational products in development (not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results